Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$120.09
-3.14%
Mkt Cap $28.05B
Analyst Ratings
Buy
26
Hold
0
Sell
0
Price Target (65 analysts)
$204.42
Range $160.00 – $245.00
Implied Upside
+70.2%
Consensus $204.42 vs current $120.09
NASDAQ·Healthcare·Biotechnology
$120.09
-3.14%
Mkt Cap $28.05B
Buy
26
Hold
0
Sell
0
Price Target (65 analysts)
$204.42
Range $160.00 – $245.00
+70.2%
Consensus $204.42 vs current $120.09